Acadia Healthcare Company, Inc. Announces 2024 Annual Meeting of Stockholders

TL;DR

<b>Acadia Healthcare Company, Inc. invites stockholders to its 2024 Annual Meeting on May 23, 2024, urging them to vote by proxy.</b>

AI Summary

Acadia Healthcare Company, Inc. (ACHC) filed a Proxy Statement (DEF 14A) with the SEC on April 9, 2024. Acadia Healthcare Company, Inc. will hold its 2024 Annual Meeting of Stockholders on May 23, 2024. The meeting will take place at the company's executive offices in Franklin, Tennessee. Stockholders are encouraged to vote by proxy. The company is mailing a Notice of Internet Availability of Proxy Materials to many stockholders. The proxy statement and 2023 Annual Report to Stockholders are available online.

Why It Matters

For investors and stakeholders tracking Acadia Healthcare Company, Inc., this filing contains several important signals. This filing is a definitive proxy statement (DEF 14A), indicating the company is formally soliciting shareholder votes for its annual meeting. The company is utilizing the 'Notice and Access' method for distributing proxy materials, which is a common practice to reduce printing and mailing costs.

Risk Assessment

Risk Level: — Acadia Healthcare Company, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational disclosures that would indicate significant risk.

Analyst Insight

Review the proxy statement for details on proposals, director nominations, and executive compensation to inform voting decisions.

Key Numbers

• 2024-05-23 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
• 2024-04-09 — Filing Date (DEF 14A filing date)
• 2023 — Annual Report Year (2023 Annual Report to Stockholders)

Key Players & Entities

• Acadia Healthcare Company, Inc. (company) — Registrant
• Christopher H. Hunter (person) — Chief Executive Officer and Director
• Securities and Exchange Commission (regulator) — Rules adopted by

FAQ

Industry Context

Acadia Healthcare Company, Inc. operates as a provider of behavioral healthcare services. This filing pertains to its annual shareholder meeting and governance.

Regulatory Implications

The filing is made under Schedule 14A of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.

What Investors Should Do

1. Review the proxy statement for proposals to be voted on at the Annual Meeting.
2. Examine the nominees for the Board of Directors and their qualifications.
3. Understand the executive compensation details presented in the filing.

Key Dates

• 2024-05-23: 2024 Annual Meeting of Stockholders — Key date for shareholder voting and company updates.
• 2024-04-09: Filing Date of DEF 14A — Indicates the formal start of the proxy solicitation period.

Year-Over-Year Comparison

This is a DEF 14A filing for the 2024 Annual Meeting, following the standard proxy statement format for shareholder engagement.

Key Financial Figures

• $0.01 — ,000 authorized shares of common stock, $0.01 par value per share ("Common Stock"), o

Filing Documents

• ny20018997x2_def14a.htm (DEF 14A) — 1243KB
• ny20018997x2_def14a-img001.jpg (GRAPHIC) — 11KB
• ny20018997x2_def14a-img002.jpg (GRAPHIC) — 6KB
• ny20018997x2_def14a-img003.jpg (GRAPHIC) — 41KB
• ny20018997x2_def14a-img004.jpg (GRAPHIC) — 50KB
• ny20018997x2_def14a-img005.jpg (GRAPHIC) — 39KB
• ny20018997x2_def14a-img006.jpg (GRAPHIC) — 39KB
• ny20018997x2_def14a-img007.jpg (GRAPHIC) — 38KB
• ny20018997x2_def14a-img008.jpg (GRAPHIC) — 34KB
• ny20018997x2_pc-img001.jpg (GRAPHIC) — 1053KB
• ny20018997x2_pc-img002.jpg (GRAPHIC) — 959KB
• 0001140361-24-018895.txt (&nbsp;) — 6711KB
• achc-20240523.xsd (EX-101.SCH) — 5KB
• achc-20240523_def.xml (EX-101.DEF) — 6KB
• achc-20240523_lab.xml (EX-101.LAB) — 10KB
• achc-20240523_pre.xml (EX-101.PRE) — 8KB
• ny20018997x2_def14a_htm.xml (XML) — 228KB

SECURITY OWNERSHIP

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 20 COMPENSATION DISCUSSION AND ANALYSIS 23 COMPENSATION COMMITTEE REPORT 40 EXECUTIVE COMPENSATION 41 DIRECTOR COMPENSATION 58 AUDIT AND RISK COMMITTEE REPORT 60 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 61 GENERAL INFORMATION 61 6100 Tower Circle, Suite 1000 Franklin, Tennessee 37067 PROXY STATEMENT This Proxy Statement is furnished in connection with the solicitation by the Board of Directors (the "Board" or "Board of Directors") of Acadia Healthcare Company, Inc. (the "Company") of proxies to be voted at the 2024 Annual Meeting of Stockholders (the "Annual Meeting"), to be held at our executive offices located at 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067, on Thursday, May 23, 2024, at 9:00 a.m. (Central Time), for the purposes set forth in the accompanying notice, and at any adjournments or postponements thereof. This Proxy Statement and the accompanying proxy are first being mailed or made available to stockholders on or about April 9 , 2024. INFORMATION CONCERNING SOLICITATION AND VOTING Record Date The close of business on March 26, 2024 has been fixed as the record date for the determination of stockholders entitled to vote at the Annual Meeting. As of such date, we had 180,000,000 authorized shares of common stock, $0.01 par value per share ("Common Stock"), of which 92,427,916 shares were outstanding and entitled to vote, and 10,000,000 authorized shares of preferred stock, $0.01 par value per share, of which no shares were outstanding. Common Stock is our only outstanding class of voting stock. Each share of Common Stock will have one vote on each matter to be voted upon at the Annual Meeting. Quorum Requirements A majority of the shares of Common Stock entitled to vote, represented in person or by proxy, is required to constitute a quorum. Abstentions and broker non-votes will be counted for purposes of determining the presence

View Full Filing

View this DEF 14A filing on SEC EDGAR